Secondary carnitine deficiencies (SCDs) may occur due to inherited defects in CPT2, CAC, or acyl-CoA dehydrogenases
These shortages will likely continue into the future and will make it hard for patients dealing with Type 2 diabetes and obesity to receive consistent treatment
GLP-1 medications may be appropriate for: Adults with type 2 diabetes Individuals with obesity (BMI 30) Individuals with overweight (BMI 27) plus weight-related conditions Patients with insulin resistance or metabolic syndrome They are not cosmetic weight-loss drugs and should not be used casually
When new treatments are approved, we will evaluate them for inclusion in our clinical protocols based on the evidence, not the hype
Glutathione is a powerful antioxidant that supports detoxification, immune function, and cellular health
Educate patients and caregivers on how to recognize respiratory depression and emphasize the importance of calling 911 or getting emergency medical help right away in the event of a known or suspected overdose (see PRECAUTIONS, Information for Patients)